Mumbai, Dec. 18 -- Sun Pharmaceutical Industries announced that the US FDA conducted an inspection at the Company's Baska facility from 8 September 2025 to 19 September 2025. The US FDA has subsequently determined that the inspection classification status of this facility is Official Action Indicated (OAI).

Published by HT Digital Content Services with permission from Capital Market....